Clinical Endpoints in Trials of Drugs for Cancer: Time for a Rethink?
BMJ: British Medical Journal 2002 June 8; 324(7350): 1389- 1391
Showing items related by title, author, creator and subject.
Registration of Drugs for Treating Cancer and HIV Infection: A Plea to Carry Out Phase 3 Trials Before Admission to the Market Koopmans, P.P. (1995-05-20)Drugs for cancer and HIV infection tend to be admitted to the market on the basis of results from phase 2 trials. Assessing the benefit-risk balance with phase 2 trials often is difficult -- the effect of the drug is usually ...
Schellhammer, Paul; Cockett, Abraham; Boccon-Gibod, Laurent; Gospodarowicz, Mary; Krongrad, Arnon; Thompson, Ian Murchie; Scardino, Peter; Soloway, Mark; Adolfsson, Jan (1997-04)